Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Shares Issued (2017 - 2023)

BioCorRx's Shares Issued history spans 8 years, with the latest figure at $600000.0 for Q2 2023.

  • For Q2 2023, Shares Issued rose 140.0% year-over-year to $600000.0; the TTM value through Mar 2024 reached $900000.0, up 63.64%, while the annual FY2022 figure was $1.2 million, 44.44% down from the prior year.
  • Shares Issued for Q2 2023 was $600000.0 at BioCorRx, up from $300000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $2.2 million in Q1 2021 and bottomed at $100000.0 in Q1 2019.
  • The 4-year median for Shares Issued is $450000.0 (2023), against an average of $750000.0.
  • The largest YoY upside for Shares Issued was 140.0% in 2023 against a maximum downside of 70.0% in 2023.
  • A 4-year view of Shares Issued shows it stood at $100000.0 in 2019, then surged by 2150.0% to $2.2 million in 2021, then plummeted by 88.89% to $250000.0 in 2022, then soared by 140.0% to $600000.0 in 2023.
  • Per Business Quant, the three most recent readings for BICX's Shares Issued are $600000.0 (Q2 2023), $300000.0 (Q1 2023), and $250000.0 (Q2 2022).